Cargando…
COVID-19-Associated mucormycosis: Case series from a tertiary care hospital in South India
The pandemic coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) is a global health problem. COVID-19 has given rise to a number of secondary bacterial or fungal infections. During the second wave of COVID-19, India experienced an epidemic of mu...
Autores principales: | Rashbi K., Shafeedha, Ali, T. M. Feroz, P. N., Deepthi, C. K., Saranya, Payyappilly, Rajan Joseph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Microbiology Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9394667/ https://www.ncbi.nlm.nih.gov/pubmed/36004359 http://dx.doi.org/10.1099/acmi.0.000360 |
Ejemplares similares
-
COVID-19-Associated Mucormycosis in a Tertiary Care Hospital in India: A Case Series
por: Singh, Shivam, et al.
Publicado: (2022) -
P295 Overview of post-covid mucormycosis in a tertiary care hospital in South India
por: Sridhar, Kripa
Publicado: (2022) -
Coronavirus Disease-Associated Mucormycosis from a Tertiary Care Hospital in India: A Case Series
por: Singh, Yudhyavir, et al.
Publicado: (2021) -
Mucormycosis in COVID-19 pandemic: study at tertiary hospital in India
por: Chavan, Reshma P., et al.
Publicado: (2022) -
Mucormycosis in a Tertiary Care Center in South India: A 4-Year Experience
por: Priya, Poorna, et al.
Publicado: (2020)